Nuvation Bio Inc (NYSE:NUVB)’s traded shares stood at 0.52 million during the latest session, with the company’s beta value hitting 1.48. At the last check today, the stock’s price was $1.95, to imply a decrease of -1.27% or -$0.02 in intraday trading. The NUVB share’s 52-week high remains $4.16, putting it -113.33% down since that peak but still an impressive 14.36% since price per share fell to its 52-week low of $1.67.
Analysts have given a consensus recommendation of Buy for Nuvation Bio Inc (NUVB), translating to a mean rating of 1.00. Of 4 analyst(s) looking at the stock, 0 analyst(s) give NUVB a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 4 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.12.
Nuvation Bio Inc (NYSE:NUVB) trade information
After registering a -1.27% downside in the latest session, Nuvation Bio Inc (NUVB) has traded red over the past five days. The 5-day price performance for the stock is -11.99%, and -19.63% over 30 days. With these gigs, the year-to-date price performance is -26.88%.
The extremes give us $7 and $7 for target low and target high price respectively. As such, NUVB has been trading -258.97% off suggested target high and -258.97% from its likely low.
NUVB Dividends
Nuvation Bio Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Nuvation Bio Inc (NYSE:NUVB)’s Major holders
The next major institution holding the largest number of shares is ECOR1 CAPITAL, LLC with 19.21 million shares, or about 7.8491% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $56.09 million.
We also have Fidelity Growth Company Fund and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Nuvation Bio Inc (NUVB) shares. Going by data provided on Dec 31, 2024, Fidelity Growth Company Fund holds roughly 13.83 shares. This is just over 4.11% of the total shares, with a market valuation of $26.9 million. Data from the same date shows that the other fund manager holds a little less at 6.13, or 1.82% of the shares, all valued at about 11.92 million.
